Sanofi Pasteur is developing a vaccine which directs the immune system to produce antibodies against C.diff toxins...C.diff is emerging as a leading cause of life threatening, health-care acquired infections worldwide...350,000 Americans are hospitalized every year due to C.diff - 77% of cases are people over 50 years old...C.diff symptoms range from mild diarrhea to life –threatening colitis and often include dehydration, abdominal pain and spasms...Even after cleaning measures, C.diff contamination has been found on 49% of surfaces in hospital rooms occupied by previous patients with C.diff...

Welcome to Cdiffense

Connecting Volunteers with Clinical Trial Information and Participating Centers